Clinical trial
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
NCT00417274 · Cleveland BioLabs, Industry · Completed
Key facts
| NCT number | NCT00417274 |
|---|---|
| Title | Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer |
| Official title | An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer |
| Lead sponsor | Cleveland BioLabs, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Cancer |
| Intervention type | Drug |
| Interventions | Quinacrine |
| Enrollment | 31 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 29, 2006 |
| Last update posted | Apr 11, 2013 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: